Session

Liver & biliary (Posters)

METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE (MAFLD) – RATHER A BYSTANDER THAN A DRIVER OF MORTALITY
METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE (MAFLD) – RATHER A BYSTANDER THAN A DRIVER OF MORTALITY

Liver & biliary (Posters)  et al.

PREVALENCE OF PERIODONTAL DISEASE IN PATIENTS WITH LIVER CIRRHOSIS AND ITS INFLUENCE ON THE SHORT-TERM OUTCOME OF THE DISEASE
PREVALENCE OF PERIODONTAL DISEASE IN PATIENTS WITH LIVER CIRRHOSIS AND ITS INFLUENCE ON THE SHORT-TERM OUTCOME OF THE DISEASE

Liver & biliary (Posters)  et al.

VITAMIN D DEFICIENCY IS ASSOCIATED WITH SIGNIFICANT STEATOSIS, ADVANCED FIBROSIS AND NON-ALCOHOLIC STEATOHEPATITIS (NASH), IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
VITAMIN D DEFICIENCY IS ASSOCIATED WITH SIGNIFICANT STEATOSIS, ADVANCED FIBROSIS AND NON-ALCOHOLIC STEATOHEPATITIS (NASH), IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)

Liver & biliary (Posters)  et al.

HEMORRHAGIC ASCITES: A POOR PROGNOSTIC MARKER IN DECOMPENSATED LIVER CIRRHOSIS
HEMORRHAGIC ASCITES: A POOR PROGNOSTIC MARKER IN DECOMPENSATED LIVER CIRRHOSIS

Liver & biliary (Posters)  et al.

ELIMINATION OF HEPATITIS C BASED ON FOCUS PROGRAM
ELIMINATION OF HEPATITIS C BASED ON FOCUS PROGRAM

Liver & biliary (Posters)  et al.

DIABETES MELLITUS INCREASES THE RISK OF HEPATOCELLULAR CARCINOMA AFTER DIRECT-ACTING ANTIVIRAL TREATMENT FOR HEPATITIS C: A SYSTEMATIC REVIEW WITH META-ANALYSIS
DIABETES MELLITUS INCREASES THE RISK OF HEPATOCELLULAR CARCINOMA AFTER DIRECT-ACTING ANTIVIRAL TREATMENT FOR HEPATITIS C: A SYSTEMATIC REVIEW WITH META-ANALYSIS

Liver & biliary (Posters)  et al.

CHRONIC HEPATITIS B GENOTYPE E: A REALITY IN A DISTRICT HOSPITAL IN PORTUGAL
CHRONIC HEPATITIS B GENOTYPE E: A REALITY IN A DISTRICT HOSPITAL IN PORTUGAL

Liver & biliary (Posters)  et al.

RISK STRATIFICATION IN AUTOIMMUNE HEPATITIS: EARLY NORMALIZATION OF TRANSAMINASES MAY IDENTIFY PATIENTS WITH SUBOPTIMAL TREATMENT RESPONSE
RISK STRATIFICATION IN AUTOIMMUNE HEPATITIS: EARLY NORMALIZATION OF TRANSAMINASES MAY IDENTIFY PATIENTS WITH SUBOPTIMAL TREATMENT RESPONSE

Liver & biliary (Posters)  et al.

DIABETES MELLITUS DOES NOT INCREASE THE RISK OF RECURRENT HEPATOCELLULAR CARCINOMA AFTER DIRECT-ACTING ANTIVIRAL TREATMENT FOR HEPATITIS C: SYSTEMATIC REVIEW WITH META-ANALYSIS
DIABETES MELLITUS DOES NOT INCREASE THE RISK OF RECURRENT HEPATOCELLULAR CARCINOMA AFTER DIRECT-ACTING ANTIVIRAL TREATMENT FOR HEPATITIS C: SYSTEMATIC REVIEW WITH META-ANALYSIS

Liver & biliary (Posters)  et al.

EFFECT OF CHOLECYSTECTOMY ON HEPATIC STEATOSIS AND INSULIN RESISTANCE ASSESSED BY CONTROLLED ATTENUATION PARAMETER (CAP) AND MRI IN NON-ALCOHOLIC FATTY LIVER (NAFLD) ALGERIAN PATIENTS: A PILOT STUDY
EFFECT OF CHOLECYSTECTOMY ON HEPATIC STEATOSIS AND INSULIN RESISTANCE ASSESSED BY CONTROLLED ATTENUATION PARAMETER (CAP) AND MRI IN NON-ALCOHOLIC FATTY LIVER (NAFLD) ALGERIAN PATIENTS: A PILOT STUDY

Liver & biliary (Posters)  et al.

INTRAHEPATIC CHOLESTASIS OF PREGNANCY – WHAT COMES NEXT?
INTRAHEPATIC CHOLESTASIS OF PREGNANCY – WHAT COMES NEXT?

Liver & biliary (Posters)  et al.

CHRONIC HEPATITIS B GENOTYPE E: CLINICAL CHARACTERISTICS AND RESPONSE TO ANTI-VIRAL AGENTS
CHRONIC HEPATITIS B GENOTYPE E: CLINICAL CHARACTERISTICS AND RESPONSE TO ANTI-VIRAL AGENTS

Liver & biliary (Posters)  et al.

LIVER STIFFNESS IS ASSOCIATED WITH DISEASE SEVERITY AND WORSE CLINICAL SCENARIOS IN CORONAVIRUS DISEASE 2019: A PROSPECTIVE TRANSIENT ELASTOGRAPHY STUDY
LIVER STIFFNESS IS ASSOCIATED WITH DISEASE SEVERITY AND WORSE CLINICAL SCENARIOS IN CORONAVIRUS DISEASE 2019: A PROSPECTIVE TRANSIENT ELASTOGRAPHY STUDY

Liver & biliary (Posters)  et al.

CLINICAL AND PATHOLOGICAL CHARACTERIZATION OF LIVER LYMPHOMAS: A RETROSPECTIVE SINGLE-CENTER STUDY
CLINICAL AND PATHOLOGICAL CHARACTERIZATION OF LIVER LYMPHOMAS: A RETROSPECTIVE SINGLE-CENTER STUDY

Liver & biliary (Posters)  et al.

NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND SEVERITY OF COVID-19 DISEASE DEPENDING ON THE ITGA2 C807T AND ITGB3 T1565C POLYMORPHISM
NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND SEVERITY OF COVID-19 DISEASE DEPENDING ON THE ITGA2 C807T AND ITGB3 T1565C POLYMORPHISM

Liver & biliary (Posters)

APOPTOSIS MARKERS IN NON-ALCOHOLIC FATTY LIVER DISEASE IN CHILDREN
APOPTOSIS MARKERS IN NON-ALCOHOLIC FATTY LIVER DISEASE IN CHILDREN

Liver & biliary (Posters)  et al.

ACUTE HAEMODYNAMIC RESPONSE TO INTRAVENOUS PROPRANOLOL PREDICTS DECOMPENSATION AND MORTALITY IN PATIENTS WITH CIRRHOSIS
ACUTE HAEMODYNAMIC RESPONSE TO INTRAVENOUS PROPRANOLOL PREDICTS DECOMPENSATION AND MORTALITY IN PATIENTS WITH CIRRHOSIS

Liver & biliary (Posters)  et al.

DIRECT ORAL ANTICOAGULANTS (DOACS) FOR OFF-LABEL USE IN PATIENTS WITH BUDD CHIARI SYNDROME (BCS)
DIRECT ORAL ANTICOAGULANTS (DOACS) FOR OFF-LABEL USE IN PATIENTS WITH BUDD CHIARI SYNDROME (BCS)

Liver & biliary (Posters)  et al.

FEATURES OF THE SERUM LONG-CHAIN FREE FATTY ACIDS CONTENT IN CHILDREN WITH NON-ALCOHOLIC FATTY LIVER DISEASE
FEATURES OF THE SERUM LONG-CHAIN FREE FATTY ACIDS CONTENT IN CHILDREN WITH NON-ALCOHOLIC FATTY LIVER DISEASE

Liver & biliary (Posters)  et al.

INSULIN LEVELS ARE ASSOCIATED TO LIVER FUNCTION TEST AND LIVER DISEASE IN COHORTS WITH UP TO 24 YEARS OF FOLLOW-UP
INSULIN LEVELS ARE ASSOCIATED TO LIVER FUNCTION TEST AND LIVER DISEASE IN COHORTS WITH UP TO 24 YEARS OF FOLLOW-UP

Liver & biliary (Posters)  et al.

Item 241 - 260 / 270
1 2 3 4 5 6 7 8 9 10 11 12
13
14